Atypical Depression - The 'Reversed' Blues
- A subtype of major depression where mood improves with positive events (mood reactivity).
- Characterized by "reversed" vegetative symptoms. Diagnosis requires mood reactivity plus ≥2 of the following:
- Hyperphagia (↑ appetite) & weight gain.
- Hypersomnia (↑ sleep).
- Leaden paralysis: heavy, leaden feeling in arms or legs.
- Long-standing sensitivity to interpersonal rejection.
⭐ High-Yield: While SSRIs are first-line, Monoamine Oxidase Inhibitors (MAOIs) are particularly effective for treatment-resistant atypical depression.

Clinical Features - Mood-Brightening Misery
- Mood Reactivity (Mood Brightening): Core feature. Mood temporarily lifts with positive events (e.g., good news). Contrasts with the pervasive low mood of melancholic depression.
- Weight Gain or ↑ Appetite: A distinct feature compared to the typical loss of appetite and weight.
- Hypersomnia: Sleeping >10 hours/day or at least 2 hours more than baseline when not depressed.
- Leaden Paralysis (Leaden Fatigue): Profound physical exhaustion; limbs feel heavy, leaden, and difficult to move.
- Interpersonal Rejection Sensitivity: Long-standing pattern of overreacting to perceived social rejection or criticism.
⭐ Key Differentiator: The presence of mood reactivity is essential for diagnosis. A patient who enjoys a social event but feels depressed again the next morning is a classic vignette.
Differential Dx - Distinguishing Despair
- Bipolar Disorder: Must rule out; screen for prior manic/hypomanic episodes. Antidepressant monotherapy risks inducing mania.
- Persistent Depressive Disorder (Dysthymia): Chronic low-grade depression for ≥2 years; less intense than a full MDE.
- Adjustment Disorder: Emotional/behavioral symptoms develop within 3 months of a stressor; marked distress but doesn't meet full MDE criteria.
- Medical Conditions: Always consider hypothyroidism, anemia, Cushing's syndrome, and neurological disorders.
- Substance/Medication-Induced: Check for drug/alcohol use or offending medications.
⭐ Always screen for bipolar disorder before initiating antidepressants. Misdiagnosing bipolar depression as unipolar can lead to treatment-induced mania or hypomania.
Treatment - MAOIs on the Menu
- MAOIs are highly effective for atypical depression, often used after failed trials of other agents like SSRIs.
- Agents:
- 📌 TIPS: Tranylcypromine, Isocarboxazid, Phenelzine, Selegiline.
- Mechanism: Inhibit monoamine oxidase, ↑ levels of serotonin, norepinephrine, and dopamine.
- ⚠️ Major Risks:
- Hypertensive Crisis: Triggered by ingesting tyramine-rich foods.
- Serotonin Syndrome: Risk when combined with SSRIs, SNRIs, or TCAs. Requires a 2-week washout period ( 5 weeks for fluoxetine).
⭐ Exam Favorite: Patients on MAOIs must avoid tyramine-rich foods like aged cheese, cured meats (salami, pepperoni), red wine, and fava beans to prevent a life-threatening hypertensive crisis.

High‑Yield Points - ⚡ Biggest Takeaways
- The hallmark is mood reactivity: mood temporarily brightens in response to positive events.
- Instead of typical neurovegetative symptoms, look for ↑ appetite or weight gain and hypersomnia.
- Leaden paralysis (a heavy feeling in arms/legs) is a classic, specific symptom.
- Features a long-standing pattern of interpersonal rejection sensitivity, causing significant impairment.
- SSRIs are first-line, but MAOIs are highly effective for treatment-refractory atypical depression.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app